Stay updated with breaking news from Robert Barrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Over 50% of patients dosed across 20 active clinical sites - - On Track for Topline Results in late 2023 - Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed")
Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.
– Over 50% of patients dosed across 20 active clinical sites – – On Track for Topline Results in late 2023 – ... | June 12, 2023
-inc-logo.png&w=240&h=240&zc=2){kind=logo}
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Rating) has been assigned an average rating of “Buy” from the nine brokerages that are currently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued ratings on the stock in the […]
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Rating) – Investment analysts at HC Wainwright decreased their Q2 2023 earnings per share estimates for shares of Mind Medicine (MindMed) in a research note issued to investors on Tuesday, May 9th. HC Wainwright analyst P. Trucchio now anticipates that the company will earn ($0.56) per share for […]